4th Masterclass of Sarcoma and Rare Cancers

Chairs: O. Ζoras, J. Duran Moreno, N. Memos

10.00-10.30 Gist: A proof on concept tumor with 10 relevant questions in 2021 A. Le Cesne
10.30-11.00 Surgery for GIST primary tumors: new laparoscopic techniques and results of neoadjuvant therapy P. Hohenberger
11.00-11.30 Desmoid tumors: modern surgical approach E. De Bree

Chairs: S. Kokkali, T. Kormas, K. Diamantopoulou

11.30-12.00 Pathology of Ewing sarcomas E. Skarpidi
12.00-12.30 Systemic treatment of Ewing sarcomas V. Papadakis
12.30-13.00 Surgical approach of Ewing sarcomas I. Papanastasiou
13.30-13.30 Interventional radiology techniques for sarcoma metastatic disease D. Filippiadis

Chairs: V. Zolota, V. Ramfidis

14.30-15.00 Pathology of EHE P. Korkolopoulou
15.00-15.30 Update on EHE treatment S. Stacchiotti

Chairs: D. Herceg, M. Bobos

15.30-16.00 Surgical approach of cutaneous sarcomas N. Memos
16.00-16.30 Cutaneous sarcomas systemic treatment J. Duran Moreno
16.30-17.00 Small tumors, big consequences: An Update on Superficial Sarcomas K. Linos

Chairs: D.J. Papachristou, I. Boukovinas, P. Papaggelopoulos

17.30-18.00 The New WHO classification of STT: evolving concepts and standing issues A.P. Dei Tos
18.00-18.30 Biomarkers to select patients for adjuvant treatment in localized soft tissue sarcoma K. Boye
18.30-19.00 Challenges in histopathological evaluation and grading of soft tissue sarcoma after preoperative oncological treatment I. Lobmaier
19.00-19.30 Immunotherapy of sarcomas J. Yves Blay
19.30-20.00 Soft Tissue Sarcomas of the Extremities: Principles of Surgical Treatment and Isolated Limb Perfusion Ν. Vassos
20.00-20.30 NAPAGE: results of a phase I/II trial A. Digklia

Chairs: I. Athanasiadis, A. Psyrri, A. Stergioula

09.00-09.30 Current insights in diagnosis and classification of retroperitoneal sarcomas G. Agrogiannis
09.30-10.00 Treatment strategy of retroperitoneal sarcoma D. Tzanis
10.00-10.30 Radiotherapy in soft tissue sarcomas J. Nixon
10.30-11.00 Update on conventional and experimental treatment options for adipocytic sarcomas P. Schöffski
11.00-11.30 An update on angiosarcoma R. Jones

Chairs: K. Boye, K. Malizos

12.00-12.30 Old school histology meets complex karyotype: an update on osteosarcomas D.J. Papachristou
12.30-13.00 Imaging of osteosarcomas M. Tzalonikou
13.00-13.30 Surgical approach of Osteosarcomas V. Kontogeorgakos
13.30-14.00 Novel therapies of bone tumors E. Palmerini

Chairs: E. Dimitriadis, A. Kyriazoglou

15.00-15.30 Sarcoma research from the lab to the clinic: hypes, hopes and successes C. Serrano
15.30-16.00 Potential molecular biomarkers of response to eribulin in patients withleiomyosarcoma A. Wozniak
16.00-16.30 Molecular characterization and clinical implication of soft tissue sarcomas: a greek sarcoma project S. Kokkali
16.30-17.00 NGS analysis for diagnostic, prognostic, and predictive biomarkers in sarcomas E. Papadopoulou

Chairs: V. Georgoulias, G. Agrogiannis

17.30-18.00 Systemic treatment based on histopathology S. Gennatas
18.00-18.30 Treatment based on molecular genetics A. Constantinidou

Chairs: D.J. Papachristou, A. Stergioula, N. Memos

18.30-19.00 Optimizing the use of trabectedin in the daily clinical practice in STS A. Kyriazoglou
Sponsored by Genesis

19.00-19.30 Quality of life in sarcoma patients O. Husson

19.30-20.00 Need for a new collaborative action in sarcoma care access I. Boukovinas

Agrogiannis G.
MD, PhD, Histopathologist, Associate Professor of Pathology
Athanasiadis I.
Medical Oncologist, Director of Oncologic Clinic MITERA Hospital, Assistant Professor of Oncology, Northwestern University, USA
Blay J.Y.
President UNICANCER, General Director, Centre Léon Bérard & University of Lyon, France
Bobos M.
MD, PhD, Pathologist, Assistant Professor of Anatomic Pathology, Dept. of Biomedical Sciences, School of Health Sciences, International Hellenic University, Alexandrian Campus, Scientific Associate “Microdiagnostics”, Thessaloniki, Greece
Boukovinas I.
MD, PhD, PharmaD, Medical Oncologist, Head of Oncology Unit, Bioclinic Thessaloniki, Greece
Boye K.
Μd, PhD, Sarcoma Oncology Head, Clinical Sarcoma Research Group, Head, National Advisory Unit for Sarcoma, Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Constantinidou A.
MD, MRCP, MSc, PhD, Medical Oncologist, Medical School University of Cyprus & BoC Oncology Centre, Nicosia, Cyprus
de Bree E.
Professor of General Surgery and Surgical Oncology, Medical School of Crete and Head of the Department of Surgical, Oncology University Hospital, Heraklion, Greece
Dei Tos A.P.
MD, Department of Pathology, Azienda Ospedale Università Padova, Department of Medicine, University of Padua School of Medicine, Padua, Italy
Diamantopoulou K.
MD, PhD, Head of Pathology Department, KAT Hospital, Athens, Greece
Digklia A.
MD, MSc, Consultant Oncologist, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland
Dimitriadis E.
PhD, Laboratory Geneticist, Department of Genetics, Saint Savvas Hospital, Athens, Greece
Duran-Moreno J.
MD, MSc, Medical Oncologist
Filippiadis D.
MD, PhD, MSc, EBIR, Assistant Professor of Diagnostic and Interventional Radiology, 2nd Department of Radiology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens
Gennatas S.
Consultant Medical Oncologist, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Georgoulias V.
Emeritus Professor of Medical Oncology, School of Medicine, University of Crete, Heraklion, Crete
Herceg D.
MD, Clinical Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia
Hohenberger P.
MD, FSSO, Head, Div. of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, University of Heidelberg, Certified Sarcoma Center, Member to EORTC-Soft Tissue and Bone Sarcoma Group, ERN-EURACAN, Greece
Husson O.
MD, Department of Medical Oncology, Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Jones R.
Royal Marsden Hospital and Institute of Cancer Research, London, UK
Kokkali S.
MD, MSc, Consultant Medical Oncologist, 1st Department of Medical Oncology, Saint Savvas Anticancer Hospital, Athens, Greece
Kontogeorgakos V.
MD, Ph.D, Associate Professor of Orthopaedic Surgery, National and Kapodistrian University of Athens, Greece
Korkolopoulou P.
Professor of Pathology, National and Kapodistrian University of Athens, Athens, Greece
Kormas T.
MD, Clinical Director, Head of Orthopaedic Surgery and Bone Tumors Division, Saint Savvas Hospital, Athens, Greece
Kyriazoglou A.
MD, PhD, Medical Oncologist, National & Kapodistrian University of Athens, 2nd Propaedeutic Department of Medicine, Attikon University Hospital, Athens, Greece
Le Cesne A.
ΜD, Doctor of Medical Oncology, Département de Médecine oncologique - Sarcomes, CLCC Institut Gustave Roussy, Villejuif, France
Linos K.
MD, FCAP, FASDP, Associate Professor of Pathology, Geisel School of Medicine at Dartmouth, USA, Bone & Soft Tissue pathology and Dermatopathology Division, Director of Bone & Soft Tissue Pathology Division, Dartmouth Hitchcock, Medical Center, USA
Lobmaier I.
Senior Consultant, Sarcoma Pathology Head, Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Malizos K.
Professor of Orthopedic Surgery & Trauma, Director of the Orthopedic Clinic, Medical School, University of Thessaly, Larisa, Greece
Memos N.
MD, PhD, MSc, Surgical Oncologist Sarcoma, Melanoma and Rare Tumors, Member of British Sarcoma Group, B’ Department of Surgery, Aretaieio Hospital, Athens Medical School, Athens, Greece
Nixon J.
Consultant Clinical Oncologist and Visiting Professor Strathclyde University, Sarcoma/Head and Neck, National Clinical Lead for Sarcomas in Scotland, NCRI UK Chair for epidemiology and Survivorship H&N cancers, Beatson West of Scotland Cancer Center, Glasgow, UK
Palmerini E.
MD, Chemotherapy Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Papachristou D.
MD, PhD, Consultant Histopathologist, Professor, Univ. of Patras, School of Medicine, Professor (Adj.), Dept. of Pathology, Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, USA, Director, Dept. of, Pathology,’’Olympion’’ General Clinic, Patras, GREECE, Vice President of the Hellenic Group of Sarcomas and Rare Cancers (EOSSO), Athens, Greece
Papadakis V.
MD, PhD, Director NHS, Department of Pediatric Hematology - Oncology
Papadopoulou E.
PhD, Group Leader of Molecular Genomics, Genekor Medical S.A, Athens, Greece
Papaggelopoulos P.
MD, PhD, 21st Department of Orthopedic Surgery, National and Kapodistrian University of Athens, Medical School, Attikon University hospital, Athens, Greece
Papanastasiou I.
MD, PhD, Orthopedic Oncologist, General Oncological Hospital Kifisias “Agioi Anargyroi”, Athens, Greece
Psyrri A.
MD, PhD, Medical Oncologist, Professor, Medical School, University of Athens, Greece
Ramfidis V.
MD, MSc, Medical Oncologist, 251 General Air Force Hospital, Sotiria General Hospital University of Athens, Athens, Greece
Schοffski P.
Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium
Serrano C.
MD, PhD, Head, Sarcoma Translational Research Laboratory, Attending Physician, Sarcoma Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Skarpidi E.
MD, DABP, FCAP, Scientific Director, Micromedia Labs, Athens, Greece
Stacchioti S.
MD, OM2 - Adult Mesenchymal and Rare Cancer Tumour, Cancer Medicine Department, National Cancer Institute, Milan, Italy
Stergioula A.
MD, Radiation Oncologist, Department of Radiation Oncology “Iaso”, Department of TomoTherapy “Iatropolis”, Department of Stereotactic Radiosurgery - CyberKnife “Iatropolis”, Athens, Greece
Tzalonikou M.
MD, Consultant Radiologist, Vioiatriki Medical Group, Athens, Greece
Tzanis D.
MD, PhD, Department of Surgery, Institut Curie, Paris, France
Vassos N.
MD, PhD, FACS, FICS, MHBA, Associate Professor of Surgery, Senior Consultant Surgeon, Division of Surgical Oncology, Department of Surgery, Mannheim University Medical Center, University of Heidelberg, Germany, Certified Sarcoma Center, Member of EORTC-Soft Tissue and Bone Sarcoma Group, Member of ERN-EURACAN
Wozniak A.
Research Manager, Laboratory of Experimental Oncology, Department of Oncology, KU Leuven Department of General Medical Oncology, University Hospitals Leuven Leuven Cancer Institute Leuven, Belgium
Zolota V.
Professor, Department of Pathology, Medical School, Univerity of Patras, Greece
Zoras O.
Professor, Department of Surgical Oncology, Metropolitan Hospital, Athens, President of the Hellenic Open University

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

Event Details